Not Yet Recruiting
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
NCT06649422
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
- Locations
-
Not specified